Chengdu Huasun Group Inc Ltd - Asset Resilience Ratio
Chengdu Huasun Group Inc Ltd (000790) has an Asset Resilience Ratio of 0.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 000790 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1995–2024)
This chart shows how Chengdu Huasun Group Inc Ltd's Asset Resilience Ratio has changed over time. See net assets of Chengdu Huasun Group Inc Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Chengdu Huasun Group Inc Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Chengdu Huasun Group Inc Ltd (000790) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥6.56 Million | 0.31% |
| Total Liquid Assets | CN¥6.56 Million | 0.31% |
Asset Resilience Insights
- Limited Liquidity: Chengdu Huasun Group Inc Ltd maintains only 0.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Chengdu Huasun Group Inc Ltd Industry Peers by Asset Resilience Ratio
Compare Chengdu Huasun Group Inc Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ipsen SA
PA:IPN |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 6.06% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 35.10% |
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424 |
Drug Manufacturers - Specialty & Generic | 2.09% |
|
Shandong Shanda Wit Science and Technology Co Ltd
SHE:000915 |
Drug Manufacturers - Specialty & Generic | 25.22% |
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SHG:688505 |
Drug Manufacturers - Specialty & Generic | 11.06% |
Annual Asset Resilience Ratio for Chengdu Huasun Group Inc Ltd (1995–2024)
The table below shows the annual Asset Resilience Ratio data for Chengdu Huasun Group Inc Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.29% | CN¥6.56 Million ≈ $959.95K |
CN¥2.25 Billion ≈ $329.13 Million |
-1.66pp |
| 2020-12-31 | 1.95% | CN¥22.23 Million ≈ $3.25 Million |
CN¥1.14 Billion ≈ $166.82 Million |
-1.90pp |
| 1996-12-31 | 3.85% | CN¥7.11 Million ≈ $1.04 Million |
CN¥184.48 Million ≈ $27.00 Million |
-1.62pp |
| 1995-12-31 | 5.48% | CN¥8.64 Million ≈ $1.26 Million |
CN¥157.76 Million ≈ $23.09 Million |
-- |
About Chengdu Huasun Group Inc Ltd
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more